bioAffinity Technologies (BIAFW) Return on Invested Capital (ROIC)
Market Cap: $26.98M
Avg Volume: -
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Return on Invested Capital (ROIC) Summary
bioAffinity Technologies's ROIC measures how effectively the company uses its invested capital to generate profits:
- Annual: -124.25%
- Quarterly: -53.14%
- TTM: -220.34%
What is ROIC?
Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.
Related Metrics
Other important metrics to assess bioAffinity Technologies's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -163.47%
- Quarterly: -61.47%
- TTM: -170.13%
- ROA (Return on Assets) - measures the return generated on the company's assets:
- Annual: -96.54%
- Quarterly: -31.70%
- TTM: -131.24%
These metrics provide insights into bioAffinity Technologies's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROIC
-124.25%
Quarterly ROIC
-53.14%
TTM ROIC
-220.34%
bioAffinity Technologies Historical ROIC
Historical ROE
Historical ROA
bioAffinity Technologies Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | ROIC | ROE | ROA |
|---|---|---|---|
| 2023 | -124.25% | -163.47% | -96.54% |
| 2022 | -35.52% | -73.84% | -66.94% |
| 2021 | 49.87% | 40.06% | -435.31% |
| 2020 | 51.43% | 48.22% | -4992.09% |
| 2019 | 12615.59% | 81.96% | -502.04% |